Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Jan 28;1(6107):204–207. doi: 10.1136/bmj.1.6107.204

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

J C Pickup, H Keen, J A Parsons, K G Alberti
PMCID: PMC1602534  PMID: 340000

Abstract

A study was performed to examine the feasibility of achieving long periods of near-normoglycaemia in patients with diabetes mellitus by giving a continuous subcutaneous infusion of insulin solution from a miniature, battery-driven, syringe pump. Twelve insulin-dependent diabetics had their insulin pumped through a subcutaneously implanted, fine nylon cannula; the basal infusion rate was electronically stepped up eightfold before meals. The blood glucose profile of these patients was closely monitored during the 24 hours of the subcutaneous infusion and compared with the profile on a control day, when the patients were managed with their usual subcutaneous insulin. Diet and exercise were standardised on both days. In five out of 14 studies the subcutaneous insulin infusion significantly lowered the mean blood glucose concentration without producing hypoglycaemic symptoms; in another six patients the mean blood glucose concentration was maintained. As assessed by the M value the level of control was statistically improved in six out of 14 studies by the infusion method and maintained in six other patients. To assess the effects of blood glucose control on diabetic microvascular disease it will be necessary to achieve long-term normoglycaemia in selected diabetics. The results of this preliminary study suggest that a continuous subcutaneous insulin infusion may be a means of maining physiological glucose concentrations in diabetics. Though several problems remain--for example, in determining the rate of infusion--longer-term studies with the miniature infusion pumps are now needed.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albisser A. M., Leibel B. S., Ewart T. G., Davidovac Z., Botz C. K., Zingg W., Schipper H., Gander R. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974 May;23(5):397–404. doi: 10.2337/diab.23.5.397. [DOI] [PubMed] [Google Scholar]
  2. Cahill G. F., Jr, Etzwiler L. D., Freinkel N. Editorial: "Control" and diabetes. N Engl J Med. 1976 Apr 29;294(18):1004–1005. doi: 10.1056/NEJM197604292941811. [DOI] [PubMed] [Google Scholar]
  3. Deckert T., Lorup B. Regulation of brittle diabetics by a pre-planned insulin infusion programme. Diabetologia. 1976 Dec;12(6):573–579. doi: 10.1007/BF01220633. [DOI] [PubMed] [Google Scholar]
  4. Genuth S., Martin P. Control of hyperglycemia in adult diabetics by pulsed insulin delivery. Diabetes. 1977 Jun;26(6):571–581. doi: 10.2337/diab.26.6.571. [DOI] [PubMed] [Google Scholar]
  5. Ingelfinger F. J. Debatees on diabetes. N Engl J Med. 1977 May 26;296(21):1228–1230. doi: 10.1056/NEJM197705262962111. [DOI] [PubMed] [Google Scholar]
  6. Molnar G. D., Taylor W. F., Ho M. M. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia. 1972 Nov;8(5):342–348. doi: 10.1007/BF01218495. [DOI] [PubMed] [Google Scholar]
  7. Parsons J. A., Rafferty B., Stevenson R. W., Zanelli J. M. Use of protease inhibitors to protect subcutaneously injected peptide hormones against local degradation [proceedings]. Br J Pharmacol. 1977 Mar;59(3):489P–490P. [PMC free article] [PubMed] [Google Scholar]
  8. Service F. J., Molnar G. D., Rosevear J. W., Ackerman E., Gatewood L. C., Taylor W. F. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970 Sep;19(9):644–655. doi: 10.2337/diab.19.9.644. [DOI] [PubMed] [Google Scholar]
  9. Siperstein M. D., Foster D. W., Knowles H. C., Levine R., Madison L. L., Roth J. Control of blood glucose and diabetic vascular disease. N Engl J Med. 1977 May 5;296(18):1060–1063. doi: 10.1056/NEJM197705052961812. [DOI] [PubMed] [Google Scholar]
  10. Slama G., Hautecouverture M., Assan R., Tchobroutsky G. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes. 1974 Sep;23(9):732–738. doi: 10.2337/diab.23.9.732. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES